• C4 Therapeutics Chief Financial Officer Kendra Adams sold 45,173 shares of common stock on Nov. 12, 2026.
• The reported sale price was $2.7115 per share.
• Adams directly owned 337,150 shares following the transaction.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. C4 Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001470831-26-001003), on November 13, 2026, and is solely responsible for the information contained therein.